Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1985 Sep;120(3):344–350.

Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

W J Martin, D M Howard
PMCID: PMC1887977  PMID: 2994482

Abstract

Amiodarone, a new antiarrhythmic agent, is associated with serious lung toxicity. This study indicates that in vitro amiodarone can directly induce bovine pulmonary artery endothelial cells to form cytoplasmic lamellar inclusions characteristic of the lung biopsy findings described in vivo. These morphologic changes occur as soon as 4 hours after incubation with the drug and with as little as 1 microgram/ml (within the therapeutic range). Amiodarone-induced endothelial cell injury, monitored by 51Cr release, occurs with as little as 10-20 micrograms/ml. The data suggest that amiodarone toxicity to the lung may be primarily related to its direct toxic effect on lung cells, and that the characteristic morphologic changes of cytoplasmic inclusions may represent an early sign of the drug's effect.

Full text

PDF
344

Images in this article

346Figure 1
on p.346
348Figure 2
on p.348

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoun G. M., Gauthier-Rahman S., Milleron B. J., Perrot J. Y., Mayaud C. M. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism. Chest. 1984 Jan;85(1):133–135. doi: 10.1378/chest.85.1.133. [DOI] [PubMed] [Google Scholar]
  2. Andreasen F., Agerbaek H., Bjerregaard P., Gøtzsche H. Pharmacokinetics of amiodarone after intravenous and oral administration. Eur J Clin Pharmacol. 1981 Mar;19(4):293–299. doi: 10.1007/BF00562807. [DOI] [PubMed] [Google Scholar]
  3. Askin F. B., Kuhn C. The cellular origin of pulmonary surfactant. Lab Invest. 1971 Sep;25(3):260–268. [PubMed] [Google Scholar]
  4. Bagdade J. D., Parker F., Ways P. O., Morgan T. E., Lagunoff D., Eidelman S. Fabry's disease. A correlative clinical, morphologic, and biochemical study. Lab Invest. 1968 Jun;18(6):681–688. [PubMed] [Google Scholar]
  5. Canada A. T., Lesko L. J., Haffajee C. I., Johnson B., Asdourian G. K. Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy. Drug Intell Clin Pharm. 1983 Feb;17(2):100–104. doi: 10.1177/106002808301700203. [DOI] [PubMed] [Google Scholar]
  6. D'Amico D. J., Kenyon K. R., Ruskin J. N. Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol. 1981 Feb;99(2):257–261. doi: 10.1001/archopht.1981.03930010259007. [DOI] [PubMed] [Google Scholar]
  7. Delage C., Lagacé R., Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J. 1975 May 17;112(10):1205–1208. [PMC free article] [PubMed] [Google Scholar]
  8. Gaton E., Wolman M. Histochemical study on the pathogenesis of chlorocyclizine-induced pulmonary lipidosis. Histochemistry. 1979 Sep;63(2):203–207. doi: 10.1007/BF00644542. [DOI] [PubMed] [Google Scholar]
  9. Gefter W. B., Epstein D. M., Pietra G. G., Miller W. T. Lung disease caused by amiodarone, a new antiarrythmic agent. Radiology. 1983 May;147(2):339–344. doi: 10.1148/radiology.147.2.6836114. [DOI] [PubMed] [Google Scholar]
  10. Heger J. J., Prystowsky E. N., Jackman W. M., Naccarelli G. V., Warfel K. A., Rinkenberger R. L., Zipes D. P. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med. 1981 Sep 3;305(10):539–545. doi: 10.1056/NEJM198109033051002. [DOI] [PubMed] [Google Scholar]
  11. Heger J. J., Prystowsky E. N., Zipes D. P. Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Am Heart J. 1983 Oct;106(4 Pt 2):931–935. doi: 10.1016/0002-8703(83)90018-2. [DOI] [PubMed] [Google Scholar]
  12. Hruban Z., Slesers A., Aschenbrenner I. Pulmonary intra-alveolar histiocytosis induced by drugs. Toxicol Appl Pharmacol. 1973 Sep;26(1):72–85. doi: 10.1016/0041-008x(73)90087-2. [DOI] [PubMed] [Google Scholar]
  13. Joelson J., Kluger J., Cole S., Conway M. Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy. Chest. 1984 Feb;85(2):284–286. doi: 10.1378/chest.85.2.284. [DOI] [PubMed] [Google Scholar]
  14. Lazarus S. S., Vethamany V. G., Schneck L., Volk B. W. Fine structure and histochemistry of peripheral blood cells in Niemann-Pick disease. Lab Invest. 1967 Aug;17(2):155–170. [PubMed] [Google Scholar]
  15. Lüllmann H., Lüllmann-Rauch R., Wassermann O. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. CRC Crit Rev Toxicol. 1975 Nov;4(2):185–218. doi: 10.1080/10408447509164014. [DOI] [PubMed] [Google Scholar]
  16. Manhem P., Paalzow L., Hökfelt B. Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension. Clin Pharmacol Ther. 1982 Apr;31(4):445–451. doi: 10.1038/clpt.1982.58. [DOI] [PubMed] [Google Scholar]
  17. Marchlinski F. E., Gansler T. S., Waxman H. L., Josephson M. E. Amiodarone pulmonary toxicity. Ann Intern Med. 1982 Dec;97(6):839–845. doi: 10.7326/0003-4819-97-6-839. [DOI] [PubMed] [Google Scholar]
  18. Marcus F. I., Fontaine G. H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J. 1981 Apr;101(4):480–493. doi: 10.1016/0002-8703(81)90140-x. [DOI] [PubMed] [Google Scholar]
  19. Martin W. J., 2nd Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis. 1984 Aug;130(2):209–213. doi: 10.1164/arrd.1984.130.2.209. [DOI] [PubMed] [Google Scholar]
  20. Martin W. J., 2nd, Powis G. W., Kachel D. L. Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells. J Lab Clin Med. 1985 Jan;105(1):23–29. [PubMed] [Google Scholar]
  21. Morady F., Sauve M. J., Malone P., Shen E. N., Schwartz A. B., Bhandari A., Keung E., Sung R. J., Scheinman M. M. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol. 1983 Nov 1;52(8):975–979. doi: 10.1016/0002-9149(83)90515-5. [DOI] [PubMed] [Google Scholar]
  22. Poucell S., Ireton J., Valencia-Mayoral P., Downar E., Larratt L., Patterson J., Blendis L., Phillips M. J. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. Gastroenterology. 1984 May;86(5 Pt 1):926–936. [PubMed] [Google Scholar]
  23. Rakita L., Sobol S. M., Mostow N., Vrobel T. Amiodarone pulmonary toxicity. Am Heart J. 1983 Oct;106(4 Pt 2):906–916. doi: 10.1016/0002-8703(83)90015-7. [DOI] [PubMed] [Google Scholar]
  24. Reasor M. J. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs. Fed Proc. 1984 Aug;43(11):2578–2581. [PubMed] [Google Scholar]
  25. Riva E., Gerna M., Neyroz P., Urso R., Bartosek I., Guaitani A. Pharmacokinetics of amiodarone in rats. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):270–275. doi: 10.1097/00005344-198203000-00016. [DOI] [PubMed] [Google Scholar]
  26. Rotmensch H. H., Belhassen B., Swanson B. N., Shoshani D., Spielman S. R., Greenspon A. J., Greenspan A. M., Vlasses P. H., Horowitz L. N. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med. 1984 Oct;101(4):462–469. doi: 10.7326/0003-4819-101-4-462. [DOI] [PubMed] [Google Scholar]
  27. STOECKENIUS W. Some electron microscopical observations on liquid-crystalline phases in lipid-water systems. J Cell Biol. 1962 Feb;12:221–229. doi: 10.1083/jcb.12.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sobol S. M., Rakita L. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. Circulation. 1982 Apr;65(4):819–824. doi: 10.1161/01.cir.65.4.819. [DOI] [PubMed] [Google Scholar]
  29. TERRY R. D., WEISS M. Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. J Neuropathol Exp Neurol. 1963 Jan;22:18–55. doi: 10.1097/00005072-196301000-00003. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES